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Personal protective equipment (PPE) is critical to protect healthcare workers (HCWs) from 
highly infectious diseases such as the Covid-19. However, hospitals have been at risk of 
running out of the safe and effective PPE including personal protective clothing needed to treat 
patients with Covid-19, due to unprecedented global demand. In addition, there are only limited 
manufacturing facilities of such clothing available worldwide, due to a lack of available 
knowledge about relevant technologies, ineffective supply chains and stringent regulatory 
requirements. Therefore, there remains a clear unmet need for coordinating the actions and 
efforts from scientists, engineers, manufacturers, suppliers and regulatory bodies to develop 
and produce safe and effective protective clothing using the technologies that are locally 
available around the world. In this review, we discuss currently used personal protective 
equipment, their quality and the associated regulatory standards. We survey the current state-
of-the-art anti-microbial functional finishes on fabrics to protect the wearer against viruses and 
bacteria, and provide an overview of protective medical fabric manufacturing techniques, their 
supply chains and the environmental impacts of current single-use synthetic fibre-based 
protective clothing. Finally, we discuss future research directions, which include increasing 
efficiency, safety and availability of personal protective clothing worldwide without conferring 
environmental problems.   
Keywords: protective clothing, sustainability, personal protective equipment (PPE), anti-
microbial, covid-19, anti-viral, medical textiles, single-use PPE and environmental impact  
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In pandemics of  highly infectious diseases such as Covid-19,1 the risk of healthcare workers 
(HCWs) being infected is much greater than the general population, as they are in direct contact 
with patients. Personal protective equipment (PPE) is considered to be a critical component 
that can be  used to protect HCWs from droplets from coughs, sneezes and aerosol generating 
procedures, in addition to other contaminated body fluids and surfaces from infected patients.2 
PPE may include aprons, gowns or coveralls, masks or respirators and goggles.3 The supplies 
of safe and effective protective clothing needed to treat Covid-19 patients have been severely 
depleted due to the unprecedented global demand. In addition, in some cases, the standard of 
PPE has not been of the required quality for medical uses, thus adding to delay and waste. A 
recent survey by Nursing Times showed that ~73% of National Health Services (NHS) nurses 
were without long-sleeved disposable gowns, eye protection and FFP3 respirators. In addition, 
~63% did not have fluid-repellent face masks due to the current crisis.4 Furthermore, PPE needs 
to be ‘donned’ and ‘doffed’ correctly, and it may be uncomfortable to wear. Although there 
have been many advisory publications from various organizations and regulatory bodies such 
as the World Health Organization (WHO), the NHS in the UK, and the Centre for Disease 
Control and Prevention (CDC) in the USA about the specification and use of PPE, there 
remains the unmet need for safer and more effective PPE for HCWs around the world, and a 
clear understanding and knowledge about the regulatory standards for such equipment. 
Medical textiles are used in the manufacturing of personal protective clothing for healthcare or 
medical applications, specifically to mitigate the risks from exposure to hazardous substances 
including body fluids, and to minimize the risk of cross-infections.5 There are several different 
types of medical clothing products, including coveralls, footwear covers, full body suits, 
gloves, independent sleeves, scrubs, surgical gowns, surgical masks and scrub hats. Medical 
textiles are also used in the manufacture of drapes and bedding textiles for healthcare settings 
as well as wound dressings, bandages and other products. Medical protective clothing, usually 
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made of synthetic fibres due to better liquid barrier properties, could be manufactured using 
nonwoven, weaving or knitting technologies. Among them, nonwoven fabrics are the most 
popular for such clothing as they facilitate relatively fast and cheap manufacturing, high levels 
of sterility and infection control. As such, they are commonly used in the manufacture of 
disposable medical textiles including surgical caps, surgical gowns and surgical masks.6 Such 
nonwoven fabrics are typically made from polypropylene, and usually have a spunbond-
meltblown-spunbond (SMS) construction.7 In contrast, woven fabrics typically made from 
cotton or polyester/cotton blends are commonly used in the manufacture of scrubs. Providing 
HCWs with protection from contaminated body fluids and other hazardous substances from 
infected patients is important, and specialist finishes can be applied to disposable or reusable 
medical textiles in order to impart protective effects. Fluid repellent finishes, for example, can 
be used to create a barrier which prevents adsorbed fluids from penetrating contact fabrics.8 A 
further challenge for HCWs is exposure to biological fluids that can transmit diseases caused 
by a variety of deadly pathogens including coronavirus (such as the coronavirus which causes 
Covid-19), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), Ebola Virus, and Human 
Immunodeficiency Virus (HIV). Anti-microbial finishes can be highly effective against such 
pathogens in preventing infections either by killing or inhibiting viruses and bacteria, and could 
be applied onto protective medical clothing via various highly scalable and cost-effective 
fabrication techniques.7, 9
While there have been many advances in high performance and functional protective clothing 
thus far, there remains a lack of comprehensive reviews that provide guidelines on the use of 
PPE, specifications and regulatory standards for PPE, a summary of fabrication techniques for 
medical protective clothing, and anti-microbial finishes of such clothing, and their 
environmental impacts and economic landscape. In this comprehensive review, we describe 
the mechanisms of viral infection, followed by a summary of the types of PPE used within 
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healthcare environment. We then discuss natural and synthetic anti-microbial agents, and their 
mechanisms to kill or inhibit pathogens. The review also discusses the various manufacturing 
techniques and anti-microbial coating techniques used, followed by the regulatory standards 
and required properties for producing protective clothing for healthcare applications. We then 
review the global market size and supply chain for such clothing and discuss the environmental 
impacts of single-use and reusable protective medical clothing. Finally, we present our views 
on current trends, future research directions and recommendations for potential solutions with 
current or future crises with PPE, due to epidemics and pandemics such as Covid-19. 
Mechanism and Transmission of Viruses
Viruses are small (~10-200 nm) infectious agents, Figure 1a, which are typically 100 times 
smaller than the average bacterium and can be most easily observed using an electron 
microscope, Figure 1b. Viruses are dependent on the “host cells” of other living organisms to 
survive, thrive and reproduce, and cannot function or replicate on their own outside of a host 
cell. A virus particle occurs as “packets” of DNA or RNA genetic material encompassed in a 
protein coating and is termed as a virion. The virion is usually composed of DNA or RNA 
genomic material, that contains the genetic instructions for reproducing the virus, and a protein 
coating called capsid, which surrounds and protects DNA or RNA, Figure 1a.10 Some viruses 
also have an outer lipid-based envelope and are known as enveloped viruses (H1N1, 
coronaviruses etc.).11 The coronavirus which causes Covid-19 has such fatty envelope, which 
can be destroyed by the application of soap-like materials. Other viruses without such an 
envelope are called naked viruses (e.g. Rotavirus). The diameter of the coronavirus is typically 
between 60 nm to 140 nm and has spike-like surface projections creating a “crown-like 
appearance” under the electron microscope, Figure 1a.12, 13
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A virus can spread via aerosols generated by coughing and sneezing in air, by vectors such as 
insects like mosquitoes, or by the transmission of body fluids such as saliva, blood or semen.14 
Once a virus infects a cell, it starts to replicate and reproduce virions rapidly, Figure 1c. As a 
result, the host cell produces more viral material than it does its own genetic material, and the 
virus could kill the host cell if left unchecked.15 The human body has some natural defenses 
against viruses, and uses its immune system to produce antibodies that bind to the viruses and 
render them incapable of replicating. The immune system also releases T-cells, which work to 
kill viruses. In addition, several vaccines have been developed to produce an artificial immune 
system to the specific viral infections. However, some viruses, including those that cause 
Acquired Immune Deficiency Syndrome (AIDS), Human Papillomavirus (HPV) infection, and 
viral hepatitis are less susceptible to natural immune responses and result in chronic infections. 
Covid-19 is another highly infectious viral disease caused by the recently discovered 
coronavirus. Coronaviruses are a large family of viruses which may cause illness in animals or 
humans. In humans, several coronaviruses are known to cause respiratory infections. The 
severity of these infections can range from mild, as in the case of the common cold but some 
are more severe as in the cases of Middle East Respiratory Syndrome (MERS) and Severe 
Acute Respiratory Syndrome (SARS). The most recently discovered Coronavirus is Severe 
Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2), which was identified in Wuhan, 
China, in December 2019 and is responsible for the Covid-19 disease.1
The main mechanisms for viral adsorption on surfaces are physical adsorption and electrostatic 
interactions, Figure 1d. The amount of virus adsorbed on a surface is the linear functional of 
the square root of time. Therefore, the more time virus stays on a surface the more opportunity 
to be strongly adsorbed onto a surface and become available to attack the population. One 
strategy to reduce viral infection is to decrease the amount of time the virus interacts with a 
material, while another strategy is to impart materials with surface properties which are 
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unfavorable for viruses. There are several factors which influence the movement of viruses or 
pathogens through fabrics, including the shape and dimensions of the microbe, the properties 
of carriers, and physicochemical nature of the fabric.2, 16 There are several pathogens that can 
be found in healthcare environments including fungi, bacteria and viruses. Such pathogens vary 
in cell dimensions and morphology, mobility, and sensitivity to environmental extremes. In 
general, fungal microbes are larger than bacterial microbes (~1–5 μm), which in turn, are larger 
than viral microbes (e.g. the size of the HIV virus is ~13 nm). Pathogens can be carried by any 
persons present in healthcare settings, and they can be transported by a variety of carriers 
including respiratory droplets expelled by coughing or sneezing, body fluids, shed skin cells, 
lint and dust.17, 18 Overall, pathogens are transmitted most easily through liquids such as 
respiratory droplets and body fluids, but they can also be transmitted without the presence of 
liquids.16
The transmission of liquid through textile materials could be described by two interchangeable 
but fundamentally different terminologies: penetration and permeation. Penetration involves 
the flow of gas, vapor or liquid through a porous material, while permeation involves the 
diffusion of gas or vapor through a porous material. Penetration and permeation usually take 
place due to a pressure gradient and concentration gradient across the barrier, respectively. 
Pathogens are larger in size than gas and vapor molecules and are considered to penetrate, and 
not permeate through materials.2 The coronavirus which causes Covid-19 have been found to 
be transmitted via aerosols.19  
Personal Protective Equipment for HCWs
About 80 million people will be working in the healthcare industry worldwide by 2030.20 
HCWs are at constant risk of exposure to pathogens and acquiring infections while treating
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patients with infectious diseases, Figure 2.2 In the last century, millions of people died from 
these highly infectious viruses, Figure 2a. This century has already seen breakouts of several 
deadly viruses including SARS, Swine Flu, MERS and the recent Covid-19 pandemic, Figure 
2b. The CDC states that such pathogens could be transmitted to human body using three 
primarily routes: direct or indirect contact with an infected person which is the most usual; 
airborne transmission; and respiratory droplet transmission though coughing, sneezing or 
talking.21 Personal Protective Equipment (PPE) for HCWs could prevent or reduce such contact 
and droplet exposures by creating a barrier between the human body and the pathogens. The 
Occupational Safety & Health Administration (OSHA) in the USA defines PPE as “specialized 
clothing or equipment worn by an employee for protection against infectious materials”. OSHA 
issued regulations that require the use of PPE in healthcare environments to protect healthcare 
personnel from any exposure to potential infectious diseases. As per the regulation, employers 
are required to supply PPE of the correct specifications to their staff. Furthermore, in the case 
of reusable PPE, employers must arrange the appropriate cleaning, repair and storage of 
products. Additionally, employers must ensure that any “end of life” PPE is disposed of 
correctly.22
Factors Affecting the Selection of PPE
The most common types of PPE within a healthcare environment are gloves, gowns or aprons, 
masks or respirators, goggles and face shields, Figure 3a-e. In order to select PPE, three 
important points need to be considered: the types and amounts of body fluids to which the 
wearer might be exposed and the ways in which these fluids might be transported; the durability 
and appropriateness of the PPE for the task; and the fit of the PPE for individual users.3 Gloves 
are the most commonly used PPE to protect hands and are manufactured from natural and 
synthetic rubbers for sterile and non-sterile usage and it is essential they comfortable, fit and 
do not tear or damage easily. Gowns are also widely used for PPE in order to protect skin and 
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other clothing, and should fully cover the torso, fit comfortably over the body, and have long 
sleeves that fit snuggly at the wrist. All or parts of face (nose, mouth and eyes) are protected 
by using a combination of PPE types such as masks or respirators, googles and face shields. 
Masks should fully cover the nose and mouth, and prevent fluid penetration; whereas goggles 
should fit softly over and around the eyes or personal prescription lenses. In some cases, face 
shields are used to substitute masks or googles, where skin protection is required in addition to 
mouth, nose, and eye protection. The face shield should cover the forehead, extend below the 
chin, and wrap around the sides of the face. HCWs are protected from hazardous or infectious 
aerosols, such as the coronavirus which causes Covid-19, and Mycobacterium tuberculosis, by 
using respirators that filter the air before it is inhaled. The most widely used healthcare 
respirators are the N95, N99, or N100 particulate respirators, which have a sub-micron filter 
capable of excluding particles that are less than 5 microns in diameter, Table 1. However, a 
higher level of respiratory protection, such as that provided by a powered air-purifying 
respirator (PAPR), is required when high-risk aerosol generating procedures such as 
bronchoscopies are being performed.3  
How to Put on (‘don’), Use and Remove (‘doff’) PPE Safely
The type of PPE used will vary based on the level of protections required and will consider 
factors such as the level of patient contact, exposure to droplets or airborne infections and 
isolation precautions.23, 24 The process for donning, using and doffing PPE should respond and 
adjust to the specific type of PPE being worn and be carried out as per the guidance from CDC, 
Figure 3d-e.3, 25 Proper hygiene should also be performed as per international recommendation 
before putting any PPE.26 The first item of PPE to be donned is the gown, followed by the mask 
or respirator. The mask or respirator should be properly adjusted to fit the face of the user. 
After the mask or respirator, it is recommended that the goggles or face-shield is put on, 
followed by gloves as the last step. While using the PPE, it is important for users to follow safe 
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working practice and avoid contamination by keeping hands away from the face and not 
touching or adjusting PPE. Gloves should be removed if they are torn, and recommended hand 
hygiene should be performed before putting on a new pair of gloves. Touching surfaces and 
other items with contaminated gloves should be avoided in order prevent the possible spread 
of pathogens.3 During the removal of PPE, self-contamination should be avoided by removing 
the most contaminated gloves first. The face shield or goggles are then removed, followed by 
the gown and then the mask or respirator.3, 25
Medical Gowns and Drapes 
Gowns are items of protective apparel designed to ensure the protection of the wearer from the 
spread of infection should they come into contact with potentially infectious liquids and solid 
materials, Figure 3a. Gowns can also prevent the transfer of the pathogens to vulnerable 
patients with weakened immune systems.27 The American National Standards 
Institute/Association of the Advancement of Medical Instrumentation (ANSI/AAMI) 
introduced standard PB70:2003, “Liquid barrier performance and classification of protective 
apparel and drapes intended for use in health care facilities” for gowns and other protective 
apparel intended for use in health care facilities in 2004. The standard describes the barrier 
protection levels of such apparel, and specifies test methods and performance levels necessary 
to verify and validate that the gown provides the necessary defined levels of protection (Section 
6). Many descriptions have been used to characterize medical gowns, however the most 
commonly used types are surgical gowns, surgical isolation gowns and non-surgical gowns. 
As regulated by the US Food and Drug Administration (FDA), both surgical and surgical 
isolation gowns are categorized as a Class II medical device that requires a 510 (k) pre-market 
notification; whereas non-surgical gowns are Class I devices, and do not require a 510 (k) pre-
market review. Surgical isolation gowns and non-surgical gowns have much larger zones of 
protection than surgical gowns. Non-surgical gowns are used in low or minimal risk patient 
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isolation situation and should never be used during surgical and invasive procedures or when 
there is a medium to high risk of contamination. Unlike non-surgical gowns, surgical isolation 
gowns could be used in medium to high risk contamination environments, whereas surgical 
gowns are suitable for any risk level (Levels 1-4).  
Mask or Respirators 
Surgical masks or respirators are used to prevent airborne particles and liquids from 
contaminating the face of the wearer. Medical masks are composed of a three-layer nonwoven 
SMS (spunbond-meltblown-spunbond) fabric laminate, Figure 2b. The inner spun-bond 
nonwoven fabric layer absorbs moisture released by the wearer and the outer layer is a 
waterproof nonwoven fabric, which is mainly used to create a barrier between the external 
liquids and the users. The middle melt-blown nonwoven fabric of polypropylene is the filter 
layer which provides protection from airborne particles. The filtering mechanism of medical 
masks is dominated by Brownian diffusion entrapment, inertial collision, gravity sedimentation 
and electrostatic adsorption. The first four physical processes are delivered by the melt-blown 
nonwoven polypropylene fabric and achieves ~35% filtration. However further electrostatic 
treatment on this layer can significantly improve the capture of aerosols or airborne particles 
through ionic interaction.  
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Performance (must be 
≥ X% efficient)
≥ 95% ≥ 94% ≥ 95% ≥ 94% ≥ 94% ≥ 95%
Test agent NaCl NaCl and
paraffin oil
NaCl NaCl NaCl and
paraffin oil
NaCl
Flow rate 85 L/min 95 L/min 85 L/min 95 L/min 95 L/min 85 L/min
Total inward leakage 
(TIL) – tested on 
human subjects each 
performing exercises



















– max pressure drop
≤ 343 Pa ≤ 70 Pa (at 30
L/min)




≤ 350 Pa ≤ 70 Pa (at 30
L/min)
≤ 240 Pa (at 
95
L/min)
≤ 70 Pa (at 30
L/min)
≤ 240 Pa (at 95
L/min)
≤ 70 Pa
(w/valve) ≤ 50 
Pa (no valve)
Flow rate 85 L/min Varied – see 
above
85 L/min Varied – see 
above




- max pressure drop
≤ 245 Pa ≤ 300 Pa ≤ 250 Pa ≤ 120 Pa ≤ 300 Pa ≤ 70 Pa
(w/valve) ≤ 50 
Pa (no valve)








 to 0 Pa ≥ 
20 sec




300 L /min for
30 sec
Depressurization
n to 0 Pa ≥ 15
sec
Force applied -245 Pa N/A -1180 Pa -250 Pa N/A -1,470 Pa
CO2 clearance 
requirement
N/A ≤ 1% ≤ 1% ≤ 1% ≤ 1% ≤ 1%
While a surgical mask may be effective in blocking splashes and large-particle droplets, it does 
not provide protection against very small air borne particles, airborne viruses or other nanoscale 
contaminants. However, an N95/FFP2 respirator provides barrier protection against at least 
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95% of very small (0.3 micron) test particles, while still allowing respiration through the 
microscopically porous shell, Table 1. N95 respirators do not usually require 510(k) pre-market 
notification in US market, and are categorized as Class II medical devices. Unlike the loose fit 
surgical mask, N95 respirators have extra filtration layers (Figure 3c) and are designed to 
achieve a very close facial fit and very efficient filtration of airborne particles. However, the 
risks of illness, being infected by viruses, or death are still not eliminated even with a properly 
fitted N95 respirator. It is worth noting, however, that a weakness of most fabric masks is that 
they seldom form a perfect seal against the face. As such, a mask which allows air to be drawn 
in through gaps caused by a poor facial seal will be ineffective, regardless of how efficient 
fabric filtration is. Nevertheless, in the light of the recent Covid-19 pandemic, several 
governments and world organizations including WHO and CDC recommended the use cloth 
face covering, especially in areas of significant community transmissions. 29, 30 In addition, 
combinations of various commonly available fabrics used in fabric masks can potentially 
provide significant protection against the transmission of aerosol particles.31, 32
Anti-Microbial Agents and Finishes 
HCWs treating patients with highly infectious diseases require high level (level-4) protection 
against pathogens. The recent Covid-19 pandemic has highlighted the urgent need for effective 
anti-viral fabrics for both medical and day-to-day apparel applications that could protect the 
wearer from potentially infectious pathogens. As per the Association for the Advancement of 
Medical Instrumentation (AAMI) PB70:2012 standard,9 protective medical clothing must be 
able to prevent virus and fluid penetration for up to an hour, and pass three tests: water impact, 
pressurizing the materials and barrier against simulated blood containing a virus. Water 
repellent or barrier finishes based on fluorocarbons have been a popular choice for hospital 
gowns to provide resistance against water and liquid.33 However, once wet they no longer 
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provide an effective barrier against pathogen ingress. Additionally, some pathogens may even 
penetrate when no visible liquid penetration is present. In addition to repellent finishes, anti-
microbial finishes have recently been widely used in medial gowns to control, destroy or 
suppress the growth of pathogens (Figure 4a) and their negative effects of odor, staining and 
deterioration.34 There are four major pathways targeted by anti-microbial agents to inhibit or 
destroy pathogens, which are cell wall synthesis, protein synthesis, nucleic acid synthesis and 
metabolic process, Figure 4b. 
Natural fibres such as cotton or wool suffer degradation, unpleasant odors, and potential health 
risks from microbial growth, due to their high surface area and moisture regain capability.35, 36 
In addition, various textile materials such as those made from cotton, poly/cotton and 
polypropylene provide favorable environments for bacteria or fungal growth, allowing such 
pathogens to survive for 1-90 days on textile materials in a hospital environment.37 
Furthermore, the polio and vaccinia viruses were found to survive on wool fabrics for up to 20 
and 14 weeks, respectively, and for shorter duration on cotton fabrics.38 Therefore, the use of 
anti-microbial textiles in healthcare facilities could diminish microbial infections compared 
with the use of textiles without anti-microbial finishes.39 A polyurethane-based anti-microbial 
material, N,N-dodecyl, methyl-polyurethane (Quat-12-PU) when coated on surfaces or electro-
spun into fibre, was able to kill airborne Gram-positive Staphylococcus aureus and Gram-
negative Escherichia coli bacteria, as well as inactivate the Influenza virus.40 In another study 
N-Halamines coated nonwoven fabrics completely inactivated Avian Influenza (AI) viruses 
and disrupted their RNA, and were found to be very effective in reducing airborne pathogens 
in the poultry production environment.41  In addition, several other studies have examined the 
use of anti-microbial finishes on textiles to inhibit the growth of viruses and found to be highly 
effective against bacteria and viruses such as Influenza viruses,42, 43 cytomegalovirus (CMV),44 
and adenovirus type 5 and poliovirus type 1.45  
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An anti-microbial agent is defined as any substance of natural, semi-synthetic or synthetic 
origin that kills (biocidal) or inhibits (biostatic) the growth of pathogens but causes little or no 
damage to the host. The term “anti-microbials” include all agents that act against all types of 
pathogens including bacteria (anti-bacterial), viruses (anti-viral), fungi (anti-fungal) and 
protozoa (anti-protozoal). In textiles applications such as clothing, anti-microbial agents need 
to be effective in providing protection from a wide variety of pathogens.46 In addition, such 
agents have to be durable to washing, dry-cleaning and ironing, simple and easy to apply on 
textiles, and should not compromise appearance and hand quality of textiles.47 Most 
importantly, the anti-microbial agent should be safe to wear next to the skin, and should not 
interfere with the skin’s natural flora.  
Mechanism of Anti-Microbial Activity
The anti-microbial effect on textiles is achieved via either cell growth inhibition (called 
“biostatic”) or killing of the pathogens (called “biocidal”). Most of the anti-microbial agents 
used in commercial textiles provide a biocidal effect via damage or inhibition of cell wall 
synthesis, inhibition of cell membrane function, inhibition of protein synthesis, inhibition of 
nucleic acid synthesis (DNA and RNA) and inhibition of other metabolic processes such as the 
disruption of the folic acid pathway, Figure 4b.48-50 In addition, the vast majority of the anti-
microbial products work by leaching when in contact with moisture, as they migrate from 
textiles surface to the external environments, to attack the pathogen.46, 47 However, the 
challenge with such anti-microbials effect is that it may also kill the  ‘good’ natural bacterial 
flora associated with the skin, and may be less durable due to exposure to the external 
environment. Another set of anti-microbial agents are those that covalently bond with the 
textile and provide greater durability, but still function by rupturing the cell wall membrane of 
pathogens to which they come into contact. 
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An anti-viral effect on a surface could be achieved via either destroying and inactivating viruses 
(called “virucidal”) or inhibiting the cell entry and/or virus replication (called “virustatic”). 
Therefore, virucidal agents (such as chlorine-based bleach and Lysol) attack and inactivate 
viruses outside of host cells by damaging their protein shell capsid, destroying the genetic 
materials such as RNA and DNA or damaging the virion structure.51 For example, metal 
nanoparticles are proven to exhibit virucidal activity against a wide variety of viruses by 
interacting with the viral surface glycoproteins directly, as well as gaining entry into an infected 
cell to destroy its genome (DNA or RNA) and stop its replication process. Moreover, metal 
particles are active against the “naked” viruses, as such particles can interact with virus 
particles in a well-defined spatial arrangement.52 However, it is easier to attack and inactivate 
enveloped viruses in comparison to naked viruses, as they can be neutralized via various 
chemical and physical methods. Several studies report binding and/or destroying anionic 
viruses via cationic surfaces or materials (polymers, metals),53 hetero-coagulation with 
positively charged aerosols,54 photocatalytic effect,55 Methylene blue photochemical 
treatment,56 nanoparticles,52 aqueous and gaseous ozone,57 anti-fouling surfaces 58 and self-
cleaning surfaces.59 
Self-cleaning and anti-fouling are important properties for anti-microbial textiles. 
Contamination of fibres by destroying and inactivating viruses and bacteria leads to a decrease 
in anti-microbial activity. Stimuli responsive polyelectrolyte multilayers attached to fibres 
provide cationic and anionic sites to neutral fibres,60 and control bacterial adhesion.61 When 
compared to uncoated fabric, a high degree of surface charge density leads to a reduction in 
adhesion of Staphylococcus aureus by 50%. Self-cleaning and anti-fouling mechanisms are 
based on both electrostatic repulsion of contaminants and the change in mechanical properties 
of polymer nano-coatings in response to biological contaminants and products of their living 
cycle62 and degradation.63 Uncharged polymer chains are in the collapsed inactive state but in 
Page 16 of 88































































the presence of biological contaminants, functional groups of the polymers become charged 
and an active gel-like nanocoating. Such reversible phase transitions in 
polycationic/polyanionic multilayers provide textiles with both anti-microbial and self-
cleaning properties. For instance, Gram-positive Lactococcus Lactis produce lactic acid which 
decreases the local pH to 4. However, when the pH reaches 4, the polymer became charged, 
the length of the charged chains increases, and the adsorbed bacteria are mechanically detached 
from the surface.62
Synthetic Anti-Microbial Agents.  
Quaternary Ammonium Compounds (QACs), a class of cationic surface-active agents (Figure 
4c),64 are commonly used in textile manufacturing as biocides. They are also used as detergents, 
softening agents or antistatic agents at different stages of textile processing such as pre-
treatment, dyeing and finishing.65 Conventionally, QACs (R4N+X−) refer to the subgroup of 
linear alkyl ammonium compounds, which is composed of a hydrophobic alkyl chain (C12-
C18) and a hydrophilic counterpart.66 Such positively charged cationic agents are usually 
attached to anionic fibres (cotton, polyester, nylon and wool) via ionic interaction.64, 67 The 
anti-microbial effect on textiles with QACs is obtained by the interaction between positively 
charged surfaces and negatively charged cell membranes of the microbes, resulting in the 
damage of the cell membranes, the denaturation of proteins and the inhibition of DNA 
replication.67, 68 QACs are effective against a broad spectrum of pathogens such as gram-
positive and gram-negative bacteria, fungi and certain viruses.64, 69 However, they suffer from 
poor durability due to the fast leaching from textiles.50 
Triclosan (2,4,4′-trichloro-2′hydroxydiphenyl ether) (C12H7Cl3O2), an odorless synthetic 
chlorinated bisphenol (Figure 4d), which does not ionize in solutions unlike other cationic 
biocides and thus improves its resistance to laundering. Triclosan is also effective against gram-
positive and gram-negative bacteria, and to some virus and fungi,67, 70-72 by blocking lipid 
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biosynthesis of phospholipids, lipopolysaccharides or lipoproteins, and affecting the integrity 
of cell membranes.67, 70 Triclosan has been used in hospitals and personal care products such 
as anti-microbial soap, tooth-paste and deodorants for decades.73 It is suitable to be applied to 
polyester, nylon, polypropylene, cellulose acetate and acrylic fibres.50 However, a number of 
leading retailers and governments in Europe have banned triclosan, because it could potentially 
cause skin irritation, as well as being non-biodegradable and toxic to aquatic and other 
organisms.74
Metal Oxide or Salts Compounds, mostly based on silver, but also on copper, zinc and cobalt 
have commonly been used as anti-microbial agents, due to their ability to bind to O, N or S 
donor ligands present in the pathogen cells, inducing oxidative stress and damaging cellular 
proteins, lipids and DNA.75, 76 Among them, silver nanoparticles (Figure 4e) have been widely 
exploited in textiles, mainly in the form of salts, due to their broad spectrum of actions on 
pathogens.77 Recently, metal nanoparticles have received significant interest because of their 
relatively higher surface area, higher solubility and faster release of the metal ions, resulting in 
a strong anti-microbial effect.78, 79 The size of ZnO nanoparticles was found to be inversely 
proportional to its antibacterial activity.78 The limitation of metal nanoparticles is their cost, 
technical and environmental challenges, and requirement of additional plasma, UV or acidic 
pre-treatment.80
Polyhexamethylene Biguanide (PHMB) ((C8H17N5)n) is a polycationic amine, which causes 
the disruption of cell membranes and lethal leakage of cytoplasmic materials by interacting 
with microbial cell membranes via electrostatic and hydrophobic interactions.67, 81, 82 The anti-
microbial activity increases with the increased level of polymerisation.83 
Regenerable N-Halamines are heterocyclic organic compounds, which contains one or more 
nitrogen and a halogen (N–X) covalent bonds, where X is usually chlorine (N–Cl) but could 
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also be bromine or iodine, Figure 4f. Such covalent bonds could be formed via the chlorination 
of an amine (RR′−NX), amide (−C(O)−NX−R) or imide (−C(O)−NX−C(O)−) group in dilute 
sodium hypochlorite. The order of stability is as follows: imide < amide < amine and in terms 
of biocidal action effectiveness is: imide > amide > amine. 64, 67, 84 N-Halamines provide 
biocidal actions against a wide variety of bacteria, fungi and viruses, which is achieved via the 
electrophilic substitution of Cl with H in the presence of water. The free Cl anions then bind 
with the acceptor regions of pathogen to prevent the enzymatic and metabolic processes of their 
cells, thus causing the destruction of pathogen.85 The imide N-Halamines work better for the 
rapid destruction of pathogens, however amine N-Halamines are the better choice for durable 
and sustainable anti-microbial properties on textiles.84, 86 The advantage of N-Halamines are 
lower cost, long term stability and action against a broad spectrum of pathogen. In addition, 
their anti-microbial effect could be recharged by using a bleaching solution during laundering. 
Such bleaching solutions usually contain sodium hypochlorite, sodium hypobromite, 
trichloroisocyanuric acid or sodium dichlorocyanurate, which donates Cl or Br to improve anti-
microbial effect with N-Halamines.87 However, the disadvantage of N-Halamines anti-
microbial finish on fabric is the presence of a substantial amount of adsorbed Cl or even other 
halogens on fibre surface that can discolor fabric and produce unpleasant odor. 
Conjugated Polymers such as Polypyrrole (PPy) are conductive polymers (Figure 4g) that are 
produced via chemical oxidative polymerization from water solutions of the monomer, and 
applied in-situ onto textile fibres, yarns and fabrics in the oxidation bath during polymerization 
process. Monomers and oligomers of conjugated polymers are very toxic.88 The presence of 
such low-molecular weight compounds in fibres after polymerization can significantly restrict 
the application of conjugated polymers for textiles that can be in contact with skin. Compared 
to other conjugated polymers such as polyaniline, PPy is more biocompatible and less 
cytotoxic.89 The anti-microbial properties of PPy is because of the presence of positive charge 
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distributed along the backbone chains, and is very effective against both Gram-negative and 
Gram-positive bacteria.90 In addition, PPy’s non-leaching behaviour provides better safety for 
both outside environments and the wearer of the garment. The report on the anti-microbial 
activity of PPy suggests that the addition of the anti-microbial agent CuCl2 to PPy increases the 
biocidal efficiency by up to 93, 98 and 100% against S. aureus, E. coli and Candida albicans, 
respectively.91 In addition, PPy has also been investigated for anti-microbial applications in 
combination with silver,92, 93 using silver nitrate as an oxidant92 or silver coated fabric.94 The 
presence of silver in PPy/silver composites increases the anti-microbial activity of coated 
fabrics by increasing the inhibition zone. The major obstacles to using of PPy and other 
conductive polymers are the presence of toxic monomers and the low processability of 
polymers. The both problems can be solved by incorporation of conjugated polymers as 
nanoparticles.95 
Graphene Materials (GMs) such as graphene, graphene oxide (GO), reduced GO (rGO), and 
graphene quantum dots (GQDs) have shown promise as a new class of broad‐spectrum anti-
microbial agents.96 Additionally, graphene-based materials have successfully been applied on 
textiles,97-100 and their scalable production methods have been reported.101-103 GO, a derivative 
of graphene, is a two-dimensional one-atom-thick sheet composed of sp2-hybridized carbon 
atoms, Figure 4h.104 In 2010, the study on the anti-bacterial activity of graphene materials (GO 
and rGO) against E. coli bacterial growth was reported. Since then, several studies104-107 have 
reported anti-bacterial activity of such materials, which is mainly due to the combined 
mechanisms of bacterial membrane perturbation caused by sharp edges, and oxidative stress 
induction. In addition, the presence of abundant oxygen containing functional groups such as 
hydroxyl, epoxy, and carboxyl groups on the graphene oxide surface enhance its hydrophilicity 
and biocompatibility, and facilitates its surface modification with other molecules or polymers 
significantly.104-106 However, there is currently no consensus in terms of the intrinsic anti-
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bacterial properties of “bare” GO.108, 109 Previous studies report that GO possesses strong,105, 
110 very weak111 or no112 anti-microbial activity, or even facilitates bacterial proliferation.113 
Nevertheless, the anti-microbial activity of graphene materials has been investigated as 
nanocomposites with other anti-microbial agents such as metal nanoparticles (mainly 
silver),114, 115 metal oxides (e.g. Cu2O),116 photocatalysts (e.g. TiO2),116, 117 quaternary 
ammonium salts (QAS) 118-121  and polymers (e.g. polypyrrole).122 In such nanocomposites, 
graphene-based materials are claimed to enhance the anti-bacterial performance mainly, due to 
their large surface and sharp edges. Only a few studies reported the broad-spectrum anti-viral 
activity of GO and GO-AgNPs composites against viruses such as pseudorabies virus (PRV, a 
DNA virus) and porcine epidemic diarrhoea virus (PEDV, an RNA virus)123 respiratory 
syncytial virus (RSV)124, 125 and Novel duck reovirus (NDRV).126 
Natural Anti-Microbial Agents 
Recently, many eco-friendly natural anti-microbial agents such as peroxy acids, chitosan and 
its derivatives or specific dyes have drawn significant interests for textiles applications, due to 
growing environmental concerns with synthetic anti-microbial agents, as well as increased 
awareness about consumer safety. For example, materials extracted from different parts of 
plants such as bark, leaves, roots and flowers containing tannin, flavonoids (Figure 4i) and 
quinonoids but also alkaloids, saponins, terpenoids and phenolic compounds, with strong anti-
microbial properties have been studied and were found to be very effective anti-microbial 
agents.127-131 In addition, essential oils have been investigated as efficient anti-microbial 
agents.130, 132 Moreover, natural dyes, extracted from bark, leaves, roots, fruits, seeds and 
flowers, or from pathogens such as fungi, algae and bacteria, could offer low-cost and 
environmentally friendly colors with inherent anti-microbial properties from different coloring 
materials such as tannin, flavonoids and quinonoids.133 Furthermore, natural anti-microbial 
peptides that are present in every living organism could be ideal candidates for anti-microbial 
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textile applications.134 The use of natural high molecular weight anti-microbial compounds  can 
overcome the issues of loss of anti-microbial activity after washing and chemical treatment, 
leaching out from the fabrics and contamination of the environment and users’ skin as well as 
high costs.90 
Chitosan (2-amino-2-deoxy-(1->4)-b-D-glucopyranan), a biodegradable, biocompatible, non-
toxic, non-carcinogenic and environmentally friendly anti-microbial agent, is derived from the 
deacetylation of chitin. It is the second most abundant biopolymer in the world after cellulose, 
which consists of 20–30% of the exoskeleton of crustaceans (Figure 4j).141 It offers a strong 
anti-microbial activity against a wide variety of pathogens, including fungi, algae and some 
bacteria. The interaction between the positively charged chitosan side groups and the 
negatively charged microbial cell membranes occurs through either electrostatic interaction, 
binding with the microbial DNA or through the excellent metal-binding capacity of chitosan 
due to its amine groups.47, 138 Chitosan could be incorporated into textiles with dyes and 
pigments due to the presence reactive amine groups139 and also with binder,140 which enables 
flexible application methods and a durable anti-microbial effect. However, chitosan suffers 
from some disadvantages for textile applications such as sensitivity to temperature, pH activity 
dependence and imparting a poor handle to the fabric. In addition, thermal curing following 
padding or exhaustion is the most common application of chitosan on textiles, and involves 
high temperature with associated energy consumption costs and possible fabric degradation. 
To mitigate such problems, UV-curing has been proposed as a fast and eco-friendly process, 
which is carried out at room temperature, with lower cost than the traditional thermal 
process.142-145 The stimuli responsive properties of chitosan are used for the design of self-
cleaning, anti-fouling and self-healing146 nano-coatings as well as the formation of polymer 
nanocarriers for release of anti-microbial compounds on demand for biomedical textiles.147 
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Table 2 Summary of Anti-Microbial Agents
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Medical textiles are typically soft goods used for healthcare and hygiene applications, and have 
been critical components in the protective healthcare sector.148 Such textiles are broadly 
categorized into: implantable (sutures, vascular grafts, artificial ligaments, etc.); non-
implantable (wound dressings, bandages and pressure garments); extracorporeal devices 
(artificial kidneys, artificial lungs, liver etc.); and protective, hygienic and healthcare products 
(surgeons’ and operating theatre wear, operating drapes and medical staff uniforms).5, 149 
Surgical textiles, which fall within the class of healthcare and hygiene products, have been in 
unprecedent demand in recent months due to the Covid-19 pandemic. Since the first Covid-19 
case was reported in China, surgical textiles such as gowns, gloves and masks have been used 
extensively in healthcare environments for the protection of HCWs, and to stop the spreading 
of the highly infectious coronavirus Covid-19. Therefore, in this section we discuss the nature 
of current surgical textiles, the associated performance standards, fibre and polymer types, and 
the fabric structures, manufacturing techniques and functional finishes used for such textiles. 
Fibre and Fabric Types
The properties of an item of protective clothing is defined by the physical and chemical 
properties of its smallest component, the fibres. The fibres, with their high surface area and 
relatively shorter length, prevent transmission of particles. Microfibers, in particular, are 
generally preferred for manufacturing barrier materials which provide higher levels of 
protection. However, less absorbent or hygroscopic fibres wick liquid along the fibre surface, 
enhancing the capillary movement of liquid which contains pathogens. Thus, less absorbent 
synthetic fibres (such as polypropylene and polyester), which neither absorb liquid nor admit 
bacteria to be trapped inside their structure, provide better liquid barrier properties than those 
of natural origin (such as cotton, wool, silk, etc.), and are commonly used for protective 
clothing. Furthermore, the capillary absorption of fibrous assembly is governed by following 
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factors:150 the characteristics of the fluid (surface tension, viscosity and density); fibre surface 
energy and surface morphology; fluid’s interaction with the fibre surface (interfacial tension 
and contact angle); and pore characteristics (size, volume, geometry and orientation). In 
addition, the level of twist in textile yarns can also influence the barrier properties of fabrics.
Medical gowns can either be “disposable/single-use” or “reusable/multi-use”. Reusable gowns, 
washed after each use, are usually tightly woven fabrics with a plain weave structure that are 
chemically finished via a pad-dry-cure process to improve liquid barrier properties. They are 
washed after each use, and used typically for more than 50 washing and drying cycles, which 
is monitored via a suitable tracking system.2 Such gowns are typically made of 100% cotton, 
100% polyester, or a polyester/cotton blend. Historically, loosely woven cotton muslin fabrics 
with high air permeability and breathability were very popular as medical textiles, however 
they were eliminated from the market due to their poor resistance to liquid penetration.7 
Cotton/polyester blend fabrics also faced the same problem, even with a 180-thread-count, 
where the blend fabrics met wearer comfort requirements but failed to resist microbial 
penetration.75 Woven polyester (T280) fabrics provided better water-repellency and increased 
protection against strike-through liquids and pathogens, but the thermal comfort could be a 
problem.151 A recent study of the North America market,152 reported that the majority of 
modern reusable surgical gowns are composed of woven polyethylene terephthalate (PET) 
fabric in the non-critical zones and knitted PET fabric in the critical zones. A barrier fabric is 
used to reinforce the knitted PET in the critical zones, where 70% of the barrier fabric is based 
on expanded polytetrafluorethylene (PTFE) and the remaining 30% is based on breathable 
polyurethane (PU) barrier membranes. 
Single-use or disposable nonwoven medical gowns and drapes are becoming the primary 
choice for healthcare professionals,153 due to their ability to provide excellent protection against 
fluids and pathogens154 as well as maintaining breathability and comfort. Single-use or 
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disposable gowns are usually composed of nonwoven fabrics and polyethylene films with a 
weight range of ~30–45 g/m2.153 Disposable gowns are typically based on synthetic fibre (such 
as polypropylene, polyester and polyethylene) nonwoven fabrics, which could be engineered 
to achieve desired properties by using particular fibre types, bonding processes, and fabric 
finishes (chemical or physical). There have also been recent approaches, such as electro-
spinning, which is a well-established technique to manufacture nonwovens made from polymer 
fibres with diameters in the rage of 100-600 nm, to produce protective clothing with improved 
comfort without compromising the protective performance. We discuss various manufacturing 
and finishing (functional) process in details for medical protective clothing in the following 
section. 
There is a considerable variation between reusable and disposable protective medical textiles 
in terms of design and performance. They both have pros and cons in terms of protection, 
maintenance, comfort, cost, and environmental impact.155 Several studies7, 152, 155, 156 have 
evaluated and compared the performance of both reusable and disposable medical gowns and 
in most cases, report that the impermeable materials are effective in reducing transfer of 
pathogens, however the thermal comfort of the wearer is adversely affected.154 Moreover, the 
disposable surgical gowns made of SMS polypropylene laminate offer higher fluid resistance 
than the gowns made of a polyester-cellulosic blend, and only allow passage of methicillin-
resistant S aureus at pressures >1 psi.157 Reusable items of protective clothing are subjected to 
abrasion and damage over time, and also undergo further mechanical stress during laundering 
processes. Indeed, several studies7, 154, 156, 158 have highlighted that laundering processes cause 
fabric to break down and, in turn, reduce a fabric’s ability to prevent the penetration of 
pathogens through its surface.  Nevertheless, gowns with reinforced layers demonstrate better 
durability to laundering. Furthermore, both disposable and reusable protective clothing have 
an environmental impact, which is discussed later in this review. 
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The fabrics used for protective medical clothing are usually of woven, knitted or nonwoven 
structure. Woven fabrics are manufactured via a weaving process, where fabrics are formed by 
interlacing or interweaving of warp (lengthwise or vertical) and weft (widthwise or horizontal) 
yarns, Figure 5a.159 Woven fabrics can be customized to have specific strength, thickness, 
extensibility, porosity, and durability by varying their weave construction, the thread spacing 
or the raw materials (fibre) structure. Such fabrics are usually strong and durable; however, 
they are less extensible than knitted fabrics, are porous and have poor barrier properties. After 
weaving, knitting is the second most popular technique for manufacturing fabrics, and it 
involves inter-looping one yarn or a group of yarns, Figure 5b. Compared with weaving, 
knitting is a faster and more economical method of converting yarn into fabrics. Additionally, 
knitted fabrics are more stretchable and have potential for very high extensibility, up to 100%, 
and offer improved comfort and a better fit in most types of apparel.160 However, knitted fabrics 
also provide poor barrier properties due to their highly porous structure. Nevertheless, the 
barrier properties of both woven and knitted fabrics can be improved by engineering a dense 
fabric structure and using hygroscopic synthetic fibres. 
The most popular fabrics for medical applications are nonwoven fabrics (Figure 5c-e), which 
are defined by ISO 9092:1988 as ‘a manufactured sheet, web or batt of directionally or 
randomly orientated fibres, bonded by friction, and/or cohesion and/or adhesion, excluding 
paper and products which are woven, knitted, tufted, stitch-bonded incorporating binding yarns 
or filaments, or felted by wet-milling, and may be additionally needled.’ Single-use disposable 
medical textiles are usually made of nonwoven fabrics alone or in combination with other 
materials (for example plastic) in order to increase fluid repellent property. Nonwoven fabrics 
are manufactured via bonding or interlocking fibres or filaments of various size and shape by 
mechanical, thermal, chemical, or solvent treatment, to provide integrity and strength to the 
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fabrics rather than the interlocking geometries associated with woven and knitted materials. In 
the manufacture of nonwoven fabrics, both staple and filament fibres can be used separately or 
in blends of different sizes and types, which are selected on the basis of the desired properties 
and performance of end products.160, 161 Fibres are arranged randomly in  a nonwoven fabric 
structure, which successfully reduces liquid transmission by providing a filtering media and 
reducing the capillary formation.162 The most commonly used nonwoven fabrics for surgical 
gowns and drapes are: spun-lace, spunbond–meltblown–spunbond (SMS) and wet-laid.7 
Synthetic fibres (such as polypropylene, polyester and polyethylene) are typically used for 
single-use items. To improve the barrier resistance, absorbency and non-slippage performance 
of both single-use and reusable products, additional materials in the forms of coatings, 
reinforcements, laminates or plastic-films are often added to obtain a composite material.7
Nonwoven fabrics are manufactured in two stages: web formation and bonding. First, the fibres 
or filaments are laid on a forming or conveying surface via drylaid, wetlaid or spunlaid 
techniques. Such web forming techniques are originate from traditional carding, suspending 
fibres in liquid and polymer extrusion techniques used traditionally in the textiles, paper and 
plastic industries, respectively. The laid fibres are then arranged in the desired orientation using 
mechanical or fluid means. Secondly, the webs are then bonded together by mechanical, 
chemical, and thermal methods to form nonwoven fabrics. In the dry-laid process, staple fibres 
are converted into web or batt structure with uniform weight per unit area via carding, garneting 
and air-laying. Meanwhile, wet-laid nonwovens are obtained by the swelling and dispersion of 
fibres in water, web formation, and drying and bonding of the web. The spun-laid process, 
which is most commonly used for protective medical textiles, involves the extrusion of the 
filaments from the raw polymer material, drawing the filaments, and laying them into a batt. It 
is a continuous polymer-to-fabric operation. There are several methods that can be used to 
produce spun-laid nonwoven fabrics including spun-bond, melt-blown, aperture films, and the 
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many-layered combinations.160, 163 The development of spun-bond technology was a major 
manufacturing breakthrough, which was followed by the development of melt-blown 
technology which enabled the production of finer micro-fibres.164 The meltblown process 
provides advantages of better filament distribution, better filtration via smaller pores between 
the fibres, softer feel, and also the possibility of manufacturing lighter weight fabrics. 
Generally, high and broad molecular weight thermoplastic polymers such as polypropylene, 
polyester and polyamide are processed by a melt-extrusion process in all commercially 
available spunlaid machines.160   
In the spun-bond process, melt fibre spinning is combined with web formation by placing the 
bonding device in line with spinning, Figure 5d. Briefly, thermoplastic polymer pellets or 
powder granules are fed from a hopper into an extrusion chamber where the polymer is heated 
to a molten state with other additives. The molten polymer is then passed through the heated 
screw and extruded from the extruder through a gear pump, which precisely controls the flow 
rate of polymer mixture, into a die block or spinpack. The spinpack, which contains a spinneret 
with thousands of micro-diameter holes, maintains uniform temperature and polymer 
distribution. The molten polymer flows through spinneret holes, jets into a quenching chamber 
and is converted into fibres which are solidified by cooling air. In the attenuator, fibres are 
stretched by high-speed air flux to reduce their diameter while travelling from the spinneret to 
a collecting belt. The flight velocity of the fibres slows down as they are collected onto a 
conveyer belt via a vacuum system which sucks the air flux and facilitates a nonwoven web 
formation on the collector belt. The untreated nonwoven fabric is then progressed to the 
bonding line by a conveyer belt, where its is bonded via a mechanical, chemical, or thermal 
process before wound onto a take-up roller.165, 166 Spun-bond fabrics provide good thermal 
properties, high tear strength and good permeability. Therefore, they are widely used in 
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hygiene-related, medical, construction and agricultural applications, as well as in other end-
uses in daily life.167
The melt-blown process, is similar to the spun-bond process in that the thermoplastic polymers 
are extruded through a spinning die, to form filament fibres, Figure 5e. The main difference 
between the spun-bond and melt-blown processes is the way in which the air is introduced to 
cool and/or attenuate the fibres as they come out of the spinneret. In the spun-bond process, the 
quenching airflow is horizontal to the vertical fibres emerging from the spinneret; whereas in 
the melt-blown process the heated air with high velocity is injected near the die tips which will 
which will converge with the filaments to attenuate them to very fine diameters. The attenuated 
filaments are quenched with cool air and collected on a moving collector screen to form a fine 
fibrous and self-bonding web.168 Since the air action is more dynamic in melt-blown 
manufacture, much finer fibres are obtained, which results in softer and weaker nonwoven 
fabrics. The attenuated filaments are generally 1–4 µm in diameter and form a very uniform 
web at low grammage. The melt-blown process is unique, as it is used almost exclusively to 
produce microfibers rather than traditional coarser textiles fibres. The fine fibre network and 
large fibre surface area of such fabrics result in enhanced filtration efficiency, excellent barrier 
properties and good wicking action. Melt-blown fabrics have been widely used for applications 
in filtration (e.g. surgical mask and respiratory filtration), insulation, and liquid and oil 
absorption.163
Composite nonwoven fabrics are also very attractive for medical applications. They offer the 
opportunity to combine strong and durable spun-bond materials with the relatively weaker 
melt-blown materials with better wicking and barrier properties, and finer and higher surface 
area fibres. Therefore, by combining the two fabric types, a spunbond-meltblown composite 
can create a single product with enhanced performance. The most commonly used nonwoven 
composite laminates are spunbond-meltblown-spunbond (SMS), spunbond-meltblown-
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meltblown-spunbond (SMMS), or spunbond-spunbond-meltblown-meltblown-spunbond 
(SSMMS) in weights ranging from 10 to 25 g/m2 comprising 1–5 g/m2 melt-blown (MB) 
microfibers. The use of polypropylene (PP)/polyethylene (PE) biocomponent materials in the 
preparation of MB webs enhances the production and properties of the composite fabrics. 
Excellent levels of protection with softness and comfort have been achieved in SMS products 
with weight ranging from 10 to 70 g/m2.153 Tri-layer anti-viral and antibacterial nonwoven 
composite fabrics with an additional anti-microbial finish on outer layer have shown level 4 
protection for surgical application, according to the barrier protection classification of 
AAMI.169, 170 To improve the barrier resistance, absorbency and non-slippage performance of 
both single-use and reusable products, additional materials in the form of coatings, 
reinforcements, laminates or plastic-film are often added.7 However, such membranes or 
reinforcements may impair comfort in applications such as medical gowns due to less heat 
transfer and more sweating.
Newer techniques such as electro-spinning have been evaluted for use in the manufacture of 
gown materials to improve comfort without sacrificing the protective performance. 
Electrospinning is one of the most simple and effective methods of fabricating ultrafine fibers 
with diameters ranging from a few nanometers to several micrometers.171 Electrospinning uses 
an electrostatic field and extrusion technology (Figure 5c) to generate ultrafine fibers in a very 
short period of time with minimum initial investment, training, and supervision. Initially, 
electrospinning received only a small amount of attention due to issues associated with low 
productivity and fibre non-uniformity. However, such issues have been resolved with the 
advancement of needleless electrospinning, near-field electrospinning and electrospinning with 
rotating strings of electrodes.172 Table 3 summaries recent progress on filtration preformance 
using electro-spun membrane. As emerging nonwoven filters, elerospun fibers have 
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successfully been applied for PM1.0 and PM2.5 level filtration and now used for personal 
proection against Covid-19.





5 Negative ions powder
6 Sodium dodecyl benzenesulfonate
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Anti-Microbial Finish Techniques 
Anti-microbial finishes can be applied to textiles by embedding an anti-microbial reagent into 
the polymer bulk during the fibre processing (Figure 5f) or by applying a surface coating or 
modification as a chemical or physical finishing treatment (Figure 5g-h). Among these 
methods, the application at the textile finishing stage is a more common and popular choice via 
traditional pad-dry-cure (Figure 5g) or exhaust (Figure 5h) techniques. The “pad-dry-cure” 
technique is the most commonly used method for applying functional or soft finishes onto 
textiles such as water repellent, anti-microbial, wrinkle free, moisture management etc. onto 
textiles. In this technique, the fabric is passed through a padding bath containing the finishing 
agent (such as anti-microbial agent), and the mangle nip rollers squeeze any excess solution 
from the fabric surface, thus producing a uniform treatment. The fabric is subsequently dried 
and cured using a stenter at recommended temperatures, Figure 5g. Such a technique provides 
very high production speed (~150 m/min)101, 103 and is applicable to a wide range of fabrics of 
different structures (woven, knit and nonwoven) and fibre compositions (cotton, polyester, 
polypropylene and nylon). The “pad-dry-cure” technique is readily scalable, and could be used 
for large-scale industrial production of protective clothing with anti-microbial and fluid-
repellent properties. Another popular method for the application of functional finishes onto 
textiles is “exhaustion” techniques, which is most commonly used to dye yarn, knit and woven 
fabrics and garments. The principle of such processing is the migration of dyes or finishing 
agent from the solution into the fibre or fabric until the dye or finishing agent has fully 
exhausted onto the fibrous materials, Figure 5h. Like the “pad-dry-cure” technique, the 
“exhaust” finishing technique is also highly scalable,102 and could be used finish tonnes (∼1000 
kg) of textiles in a short period, providing an even distribution and good wash fastness of 
finishing agents. To improve the durability of anti-microbial finishes to the fabrics, cross-
linkers183, 184 are used to introduce intermolecular covalent bridges between the polymer chains 
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and the antibacterial molecule by chemical,185 radiation186 or physical methods.187 In addition, 
surface modification methods, such as oxygen plasma treatment, ultrasound technology, UV 
radiation, surface bridging and enzyme treatment, have all been investigated for improving the 
durability of anti-microbial finishes on natural fibre-based products.188 
The other popular approach is to incorporate the anti-microbial agents into the polymer matrix 
of the textile fibres before or during spinning or during the web formation process. Such agents 
can be mixed (commonly by melt-mixing) with polymer granules prior to production, or added 
to the reservoir chamber during the extrusion or electro-spinning process, Figure 5f.67, 189, 190 
Several studies191-193 report electro-spinning of nanofibers based on polymers and nanoparticles 
with anti-microbial properties, that provide several advantages such as higher surface area to 
volume ratio, adjustable porosity and the ability to customize nanofiber composition. 
Additionally, the approach of mixing anti-microbial agents into thermoplastic polymers for 
fibre spinning or web formation processes has received substantial interests due to their 
durability and scalability it offers. Furthermore, such method has no negative effect on the 
mechanical properties of the fibrous end product. However, it requires a higher extrusion 
temperature and the anti-microbial agents are usually trapped in the polymer matrix, which 
restricts their ability to diffuse through the matrix to perform their biocidal or biostatic function. 
Thus, such an approach would potentially provide a lower anti-microbial effect and be limited 
to anti-microbial agents that are stable at higher temperature such as metallic particles.189, 194, 
195   There are also natural fibres with intrinsic anti-microbial properties based on chitosan and 
cellulose fibres, however their anti-microbial effect is generally less effective.50
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Table 3. Typical Standards for PPE
PPE Types Category Standards Key Requirements 
Surgical Medical Face 
Mask
Category II: 
Medium risk  
BS EN 14683:2019 
(UK/EU)                        
ASTM F2100 (US)
 Mask must be marked as Type IIR
 Splash resistance pressure ≥ 1200mm Hg
 Bacterial filtration efficiency (BFE) ≥ 98%, simulated 
with particles size of 3.0 μm 
 Single-use and anti-fogging





NIOSH-42C FR84 (N95 
– US)
 
 Protect the wearer from airborne particles and from 
liquid contaminating the face
 Blocks at least ≥94% (FFP2) or ≥95% (N95/KN95) of 
very small (0.3 μm) test particles;
 Single-use and close fitting 
 Filtering specific amounts of viruses or bacteria, 
reducing the amount of and/or killing viruses, 
bacteria, or fungi, or affecting allergenicity, or
 contains coating technologies unrelated to filtration 





BS EN 13795:2019 
(performance)               
BS EN11810:2015 (fire 
resistance) 
 Hydrostatic pressure: >20cm H2O (Standard Lite), 
>50cm H2O (Standard) and >1000cm H2O (Standard 
High-performance gown)






BS EN 13795:2019 
(performance)               
BS EN11810:2015 (fire 
resistance)
 Hydrostatic pressure: >20cm – 28.4cm H2O (Fluid 
resistant isolation gown - low exposure to fluid), 
>57.3cm H2O (Fluid resistant isolation gown -medium 
exposure to fluid), >91cm H2O (Impervious isolation 
gown -high exposure to fluid)
 Must be single-use, latex free, lint free, fire resistant 
and antistatic 








BS EN 14126:2003 (all 
including 5 test methods) 
BS EN 943-1:2019 (1a, 
1b, 1c and 2B coverall)
BS EN 
14605:2005+A1:2009 
(type 3B and 4B 
coveralls)




 Single-use, latex free and antistatic
 BS EN 943-2:2019 (1a, 1b, 1c and 2B coverall):
 Protective clothing against liquid and gaseous 
chemicals, aerosols and solid
 particles. Performance requirements for ventilated and 
nonventilated "gas-tight" (Type 1) and "non-gas-tight" 
(Type 2) chemical protective suits.
 BS EN 14605:2005+A1:2009 or any equivalent 
standard
 Protective clothing against liquid chemicals. 
Performance
 requirements for clothing with liquid-tight (Type 3) or 
spray-tight (Type 4)
 connections 
 BS EN ISO 13982-1:2004+A1:2010 or any equivalent 
standard Protective clothing for use against solid 
particulates. Performance requirements for chemical 
protective clothing providing protection to the full 
body against airborne solid particulates (type 5 
clothing)
Level 1 
Minimal Risk  
ANSI/AAMI PB 70:12 
AATCC 42
 Impact Penetration (water) ≤4.5 g 
 Application: basic care, standard hospital medical unit 
Level 2
Low risk  
ANSI/AAMI PB 70:12 
AATCC 42 & 127
 Impact Penetration (water) ≤1.0 g
 Hydrostatic Pressure ≥20 cm
 Application: Blood draw from a vein, Suturing, 













Medium Risk   
ANSI/AAMI PB 70:12 
AATCC 42 & 127
 Impact Penetration (water) ≤1.0 g
 Hydrostatic Pressure ≥50 cm
 Applications: Arterial blood draw, Inserting an IV, 
Emergency Room, Trauma
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ANSI/AAMI PB 70:12 
ASTM F1670 & F1671 
Phi-X174
 Synthetic Blood (for surgical drapes) and
 Viral Penetration Test (for surgical and isolation 
gowns): no penetration at 2 psi
 Applications: Pathogen resistance, Infectious 
diseases (non-airborne), Large amounts of fluid 
exposure over long periods
Eye protection 
(shields/safety glasses
BS EN 166:2002 
(UK/EU)         
ANSI/ISEA Z87.1-2010 
(US)
 Must be optically clear;
 Must be resistant to fogging; and
 Adjustable head band
Gloves Category I & 
III: Low & 
High risk
EU standard directive 
93/42/EEC, EN 455         
EU standard directive 
89/686/EEC Category III, 
EN 374                 
ANSI/ISEA 105-2011 
ASTM D6319-10 (US)




 Outer gloves should preferably reach mid-forearm 
(minimum 280 mm total length)
 Different sizes
Standards and Requirements for Protective Medical Clothing 
The protective clothing products used in healthcare environments are considered as medical 
devices, and are therefore subject to stringent regulations. Such clothing is required to meet or 
be equivalent to certain standards originated under the auspices of the International Standards 
Organization (ISO), European Committee for Standardization (CEN) or under various US 
standards organizations (e.g. ANSI/AAMI, ASTM). The selection and use of personal 
protective clothing depend on the hazards and the risks that a wearer is exposed to. Therefore, 
a first critical step is to identify and assess the physical and health hazards (i.e. risk and hazard 
assessment) in the workplace. The standards will then enable the selection of the appropriate 
protective clothing or PPE based on the risk and hazard assessment. There are mainly three 
types of standards: test methods, product or performance specifications, and technical reports 
or guidance documents.196 Test methods usually describe a testing method simulating the real-
life exposure of protective clothing and what would be observed. The product or performance 
specification standards set the pass or fail criteria for protective clothing by defining the levels 
of performance that must be met for different properties related to hazards or risks. The 
guidance documents provide useful information about the selection, correct use and 
maintenance of protective clothing. 
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For EU and UK markets, PPE must conform to European Commission (EC) regulations 
2016/425, which covers the design, manufacture and marketing of personal protective 
equipment. CE marking must be clearly evident on the product and/or packaging. CE marking 
is defined as a certification mark, which indicates that a product conforms with health, safety, 
and environmental protection standards for products sold within the European Economic Area. 
In addition, any products containing phthalates should be packaged in such a way that this 
information is clearly indicated in accordance with medical devices regulation 2017/745. 
Furthermore, the products and packaging should be latex free with a minimum 3-year shelf life 
from the date of manufacture, and instructions for use and disposal/recycling instructions for 
use and disposal/recycling. As per EU 2016/425, PPE is generally categorized into three types 
on the basis of the risks and hazards a wearer is subject to: Category I (minimal risk), Category 
II (PPE not covered within category I or III) and Category III (high risks that may cause very 
serious consequences such as death or irreversible damage to health).197 In the US, all PPE is 
regulated by FDA, and should meet applicable voluntary consensus standards for protection. 
Pre-market Notification or 510(k) clearance is required for some PPE before it can be legally 
sold in the US. In such cases, PPE is reviewed by the FDA to make sure it meets specific 
criteria for performance, labelling, and intended use to demonstrate substantial equivalence by 
conforming to consensus standards for barrier performance and resistance to tears and snags. 
In addition, voluntary consensus standards may also be used to demonstrate sterility (when 
applicable), biocompatibility, fluid resistance, and flammability.
Functional/Barrier Properties Against Pathogens
Pathogens are transported by carriers such as body fluids, sloughed skin cells, lint, dust, and 
respiratory droplets. Therefore, protective clothing with functional properties such as 
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protection against liquids and pathogens are extremely important for healthcare applications.198 
In order to determine the ant-viral activity of textile materials, ISO 18184:2019 has been 
developed and provides a quantitative test method to assess the anti-viral performance of such 
products against specific viruses including SARS-CoV2 (NL63).199 Recently, several 
commercial products claimed that their products were effective against coronavirus (kills such 
viruses) after testing their anti-viral performance against human coronavirus (NL63) as per ISO 
18184:2019. In addition, several standard test methods have been developed to investigate the 
functional performance of protective clothing against liquids and pathogens by simulating real 
life conditions.200  Such test methods include the water impact penetration test, the hydrostatic 
pressure test, resistance to liquid penetration,201 and protection against pathogen.202 The EN 
13795 European Standard for surgical gowns and drapes specifies the performance 
requirements, manufacturing standards and testing methods for both reusable and single-use 
surgical drapes, gowns and clean-air products. In this standard, the barrier performance of the 
protective clothing against liquid and pathogens is tested by liquid penetration resistance test 
(EN IS0 811:2018), wet microbial penetration resistance test (EN ISO 22610:2006) and dry 
microbial penetration resistance test (EN ISO 22612:2015).203 In the US, American National 
Standards Institute (ANSI) and the Association of the Advancement of Medical 
Instrumentation (AAMI): ANSI/AAMI PB70:2003 identifies four levels (Level 1 to 4: 
Minimal to high risk) of protection based on barrier performance against liquids and pathogen. 
Such levels of protection are assessed by the spray impact penetration test, the hydrostatic head 
test, and synthetic blood (for surgical drapes) and viral penetration test (for surgical and 
isolation gowns). Table 2 shows the characteristics to be evaluated and performance 
requirements for surgical gowns as per BS EN 13795-1:2019. As per the standard if the 
manufacturer does not categorize product areas, all areas of the protective clothing should meet 
the requirements for critical product areas. 
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Table 4. Characteristics to be Evaluated and Performance Requirements for Surgical 
gowns (BS EN 13795-1:2019)203
Physical Properties
The protective garment should be durable enough to last the intended lifecycle. The critical 
physical and mechanical properties need to be considered while selecting protective clothing, 
which include tensile and burst strength, dimensional stability and lint generation. Such 
properties are assessed by tensile test (EN 29073-3 or ASTM D5034, ASTM D1682), burst test 
(EN ISO 13938-1) and lint generation test (EN ISO 9073-10). In addition, the seam strength 
(ASTM D751) and the barrier properties of seams/closures are critical to provide the overall 
barrier protection by fluid-resistant or impermeable garments. Several seaming techniques with 
barrier properties are used in the construction of protective clothing. Examples of durable and 
effective seams include serged or sewn, bound, taped, double taped, and ultrasonic welded 
seams. Furthermore, HCW should also know the appropriate size of their protective garments 
as it may catch or snag on objects if they are too large. PPE that fits well and is comfortable to 
wear will encourage employee use of PPE. The American national standard ANSI/ISEA 101-
2014 provides a sizing chart and a set of exercises in which a user can validate whether that 
garment is the “proper” size.198 All reusable protective clothing and linen should be laundered 
Requirement
Standard Performance High Performance















Microbial Penetration — Dry EN ISO 22612 CFU Not required ≤ 300 Not required ≤ 300
Microbial Penetration — Wet EN ISO 22610 IB ≥ 2,8 Not required 6,0 Not required
Liquid Penetration EN ISO 811 cm H2O ≥ 20 ≥ 10 ≥ 100 ≥ 10
Cleanliness Microbial / Bioburden  EN ISO 11737-1 CFU/ 100 cm2 ≤ 300 ≤ 300 ≤ 300 ≤ 300
Particle Release EN ISO 9073-10 log10 (lint count) ≤ 4,0 ≤ 4,0 ≤ 4,0 ≤ 4,0
Bursting Strength — Dry EN ISO 13938-1 kPa ≥ 40 ≥ 40 ≥ 40 ≥ 40
Bursting Strength — Wet EN ISO 13938-1 kPa ≥ 40 Not required ≥ 40 Not required
Tensile Strength — Dry EN 29073-3 N ≥ 20 ≥ 20 ≥ 20 ≥ 20
Tensile Strength — Wet EN 29073-3 N ≥ 20 Not required ≥ 20 Not required
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at 71°C for a minimum of 3 minutes or 65°C for at least 10 minutes as per BS EN 14065:2016 
standard and still provide the specified protection after washings.204
Comfort
Surgeons are less likely to tolerate poor thermal comfort and fit while wearing personal 
protective clothing. A balance between the heat loss and gain of a human body is needed to 
enable thermal comfort. Such thermal comfort with a medical gown depends on the surgical 
environment, length of procedure and amount of exposure.148 The temperature and relative 
humidity of an operating room are usually ~15.6-25.6 °C and 30-60%, respectively. However, 
the operating room temperature could increase during the procedure due to the radiant heat 
from the overhead lighting. In addition, doctors and nurses’ own body heat released in a high-
stress environment under strong lighting add to the feeling of discomfort,205 which may 
contribute to increased mistakes, impaired performance, and less efficient work.7 Therefore, 
protective medical clothing should provide an isothermal environment for HCWs during use. 
To improve barrier resistance, absorbency and non-slippage performance of both single-use 
and reusable protective clothing, additional materials in the form of coatings, reinforcements, 
laminates or plastic-film are often added.7 However, such membranes or reinforcements may 
impair the wearing comfort of the reinforced gowns due to less heat transfer and more sweating 
in areas where the gown is covered by another layer of fabric or a plastic. To provide enhanced 
protective medical garments without comprising the comfort/breathability, several advanced 
technology-based approaches have been introduced to increase the permeability and flexibility 
of the fabric. For example, phase change materials have been used to improve the regulation 
of the temperature of treated fabrics within the normal comfort range.206 Another approach is 
to use layered, breathable materials with an active cooling mechanism. Because of the 
environments in which they work and the nature of the tasks which they must perform, 
surgeons tend to express a preference towards comfortable products which have moisture 
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management properties while also provide a high level of protection. To achieve such clothing, 
an impervious “breathable” plastic film is sandwiched between two layers of spun-bonded 
nonwoven, allowing moisture vapor to pass through the fabric from the inside of the garment, 
but prevent the passage of fluids or pathogen from outside.207   
Biocompatibility
A biocompatibility test of protective medical clothing has been developed to determine its 
compatibility with a biological system, and fitness for human use. The International 
Organization for Standardization (ISO) established ISO 10993-1: Biological evaluation of 
medical devices - Part 1: Evaluation and testing within a risk management process, for 
evaluating the biocompatibility of a medical device prior to a clinical study. The 
biocompatibility test involves the application of a high temperature to a medical device to 
extract leachable materials, and then investigating potentially harmful chemicals or 
cytotoxicity in the leachable extracts. There are range of biocompatibility tests available, from 
a skin irritation test to hemocompatibility and implantation tests, which could be in vitro or in 
vivo or both depending on the intended use. The FDA recommends that cytotoxicity (ISO 
10993-5), sensitization (ISO 10993-10), and irritation or intracutaneous reactivity (ISO 10993-
10) is evaluated for a medical device that is contact with the skin.27, 208     
Global Market and Supply Chain for Personal Protective Clothing 
 The global market size of personal protective products was valued at ~ $50.93 billion in 2018, 
and is expected to grow up to ~$79.66 billion at a compound annual growth rate (CAGR) 
~6.6% from 2018-2024, Figure 6a.209 In 2019, China was the largest exporter of personal 
protective products with a ~17.2% market share followed by Germany and USA, Figure 6b.210 
The protective clothing market for healthcare industry was valued at ~$1.2 billion, and forecast 
to reach ~$1.7 billion by 2024 at a CAGR ~6.5%.211 As expected, the demand for medical 
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protective clothing in North America was the highest (~$0.49 billion) followed by Europe 
(~$0.32 billion), and was forecast to continue to grow until 2024 (Figure 6c) at a CAGR of 
~6.9% (North America) and ~5.7% (Europe), respectively, due to the presence of 
technologically advanced countries in these regions and stringent regulations regarding the use 
of protective clothing in every industry. South America and Asia-Pacific (APAC) are also 
projected to experience high growth in the global protective clothing market during the forecast 
period. The markets in these regions are estimated to register CAGRs of 7.0% and 6.4%, 
respectively, between 2019 and 2024. Such growth is mainly driven by the manufacturing 
industry and rapid urbanization in these regions. China is the largest market for protective 
clothing in APAC.211 
Since the outbreak of COVID-19 in December 2019, there has been a surge in demand for 
personal protective equipment (PPE) products, notably surgical masks and gowns which are 
made from polypropylene nonwoven fabrics. In 2018, nonwoven fabrics accounted for a 64.3% 
share of the global medical textiles market in volume terms. Prior to the COVID-19 pandemic, 
global demand for nonwoven fabrics for the medical sector was projected to grow by an 
average of 5.0% per annum between 2018 and 2025.212 However, during the Covid-19 
pandemic, several hospitals around the world reported that supplies of PPE were running low. 
Indeed, a recent survey showed that over 30% and 21% of doctors working in high-risk areas 
during the pandemic reported shortages of long-sleeved disposable gowns and FFP3 masks or 
respirators, respectively, Figure 6d.213 Therefore, it can be assumed that this growth figure will 
have accelerated in light of the global Covid-19 outbreak. 
Overall, producers of nonwoven fabrics account for some 70% of global polypropylene fibre 
demand. As a result of the surge in demand for nonwoven fabrics following the Covid-19 
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pandemic, prices for polypropylene fibre in Asia increased during April 2020 particularly in 
China. China is the largest producer of many of the raw materials required in the manufacture 
of PPE, and it is also the largest supplier of finished PPE products. Other PPE supplying 
countries include Taiwan, India, Japan, South Korea, Malaysia, Mexico, Thailand, the USA, 
and several countries in Europe.214 The supply of PPE and associated raw materials has been 
disrupted during the Covid-19 pandemic, not least because government-imposed lockdowns in 
China disrupted manufacturing operations in the country during February 2020. Since March 
2020, PPE manufacturing operations in China have largely returned to normal, although there 
is still some concern regarding the supply of raw materials.214 However, increasing numbers of 
companies in China are turning to the manufacture of polypropylene fibre in light of the 
increase in demand.215 
Some countries have imposed export bans on PPE products following the COVID-19 outbreak. 
The Indian government, for example, has imposed an export ban on all PPE products and 
associated raw materials. In addition, the EU has enforced a regulation to prevent the export of 
PPE without authorization from the manufacturing member state. Overall, demand for PPE 
during the Covid-19 pandemic appears to be outstripping supply,216 and this is a cause for 
concern. Furthermore, ensuring adequate supply of PPE is particularly challenging for low 
income countries and middle-income countries, whose governments cannot afford to compete 
against high income countries in bidding wars for PPE. To help meet increasing demand for 
PPE and other medical apparel such as scrubs, several companies which usually manufacture 
consumer products have converted their production lines to manufacture PPE or medical 
scrubs. Several such companies are concentrating on boosting domestic supplies in the light of 
global shortages of PPE and other medical apparel.214  
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Environmental Impact  
The environmental impacts of the textile industry are well-documented, and the textile industry 
is reported to be the second largest polluter of the environment after the oil industry, by 
contributing to ~8-10% global CO2 emission and ~20% of the global waste.217 About 95% of 
textiles are fully recyclable, however 85% of all textiles are still sent to landfill or 
incinerated.218 Synthetic fibres such as polyester, which dominate the textiles market due to 
their low cost and performance characteristics, are biggest source of carbon emission. Since 
synthetic fibres provide better protection against pathogens, protective clothing products for 
healthcare applications-particularly single-use surgical products- are predominantly made of 
polypropylene or polyester. At the end of their useful lives, such products are either incinerated, 
thereby generating further carbon emissions, or sent to landfill, where they can persist for years 
(~450 years) due to their non-biodegradability. Thus, the environmental impacts of such 
clothing are significant. Indeed, it is estimated that, during the Covid-19 pandemic, frontline 
workers worldwide are using some 44mn nonwoven PPE items on a daily basis, the majority 
of which are made from polypropylene. This, in turn, is resulting in the generation of some 
15,000 tons of waste every 24 hours.219 However, it is challenging to accurately assess these 
environmental impacts due to their complex supply chains and lack of extensive studies in this 
area. Nevertheless, in this section we discuss the current understanding of the environmental 
impacts of the protective medical clothing on energy consumption, carbon footprint, blue water 
consumption and solid waste generation. We also compare the environmental impacts of 
synthetic fibre-based clothing with the most commonly used natural fibres such as cotton. 
Polyester dominates worldwide fibre consumption with ~55% of the total textile fibre by 
volume, followed by cotton (~27%). By contrast, the consumption of polypropylene fibres is 
far less as they are used for very specialized applications such as surgical masks and medical 
gown. However, the consumption of polypropylene fibres has seen a significant rise in recent 
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months due to the Covid-19 pandemic. Synthetic fibres consume the highest amount of energy 
during the fibre manufacturing, as they are usually manufactured from fossil fuels. For 
example, the production of polyester and polypropylene consumes almost double the amount 
of energy compared with that of cotton fibres. Additionally, greenhouse gas emission (GHG) 
is also influenced by the energy consumption rate and the sources of the energy consumption 
during textile processing including spinning, weaving, dyeing and finishing. For example, coal-
based energy sources used in China have a higher carbon footprint than that of other ‘greener’ 
sources used in Europe. The textile industry also uses large amounts of water, ~79 billion m3 
in 2015 alone, and about 90% of this consumption is associated with the cultivation and wet 
processing of cotton-based textile materials. Cotton fibres therefore have the highest water-
footprint among textile fibres. In reviewing the Higgs Materials Sustainability Index (MSI) 
score from the life cycle assessment (LCA) to understand and quantify the sustainability 
impacts of polyester, polypropylene and cotton textiles, it is apparent that the fossil fuel 
consumption associated with polyester and polypropylene is higher, which, in turn, results in 
higher global warming, Figure 6e-f. However, the cotton fibre contribution to water 
usage/scarcity is substantial, and to eutrophication is higher than polyester and polypropylene, 
Figure 6e-f. Nevertheless, natural fibres such as cotton are biodegradable unlike synthetic 
fibres which can remain in the environment for hundreds of years.  
Medical textiles including surgical gowns are available as reusable and disposable products. 
The recent Covid-19 pandemic has driven the market towards single-use disposable products 
due to hygiene concerns, and the need to avoid spreading infection or diseases. After use, all 
single-use PPE are discarded using standard infection control measures. NHS England usually 
labels waste as either infectious (contaminated with bodily fluids), offensive (contaminated but 
not infectious) or municipal (similar to household disposals). All infectious PPE waste is 
incinerated at high temperature. However, such processing is expensive and emits unwanted 
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toxic gases, which contributes toward the overall pollution and carbon emission. Nevertheless, 
modern gas cleaning or ‘scrubbing’ technologies can remove these potentially harmful gases 
and additionally, the heat generated from waste incineration could be used as a source of 
energy. In the UK, waste incineration contributes ~2% of the total energy generation. Other 
medical waste, which is not incinerated, is usually discarded in a landfill, while a very small 
proportion is recycled. It is worth noting that, in the case of non-PPE clothing, by doubling a 
garments’ lifetime it is possible to reduce GHG emission by ~44%, and save $460 billion each 
year. To become environmentally sustainable, it is therefore important to reuse and recycle 
textile materials. Similarly, there is a growing interest in reusable medical textiles due to better 
environmental sustainability. A recent study shows that the selection of reusable medical 
apparel could reduce natural resource energy consumption (~64%), greenhouse gas emissions 
(~66%), blue water consumption (~83%), and solid waste generation (84%), Figure 6f.152  
The environmental impact of anti-microbial textiles is also a growing global concern, which is 
mainly associated with anti-microbial chemical production, their application on textile 
materials, and the subsequent use and disposal of such products.66 The ideal anti-microbial 
agents would have high efficacy at low dosing, be durable to washing, and their effectiveness 
should outweigh the potential environmental consequences and the cost of their usage.50 In 
addition, the removal of such agents from textile waste water is important in order to avoid 
discharge to the wider aquatic environment. For example, silver is one of the most popular anti-
microbial agents and is non- biodegradable. Silver is immobilized by the formation of stable 
sulphide complexes, which are insoluble and much less toxic and bioavailable than dissolved 
silver. Thus, the potential risk with silver in the aquatic environment is reduced by removing 
85%–99% of silver during the textile waste water treatment.66, 220 Additionally, the health 
impact of anti-microbial agents needs to be considered in order to evaluate the safety of anti-
microbial compounds for animals and humans. The extent to which humans could be exposed 
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to anti-microbial textiles is usually influenced by the type of action of the anti-microbial agent 
(diffusion or contact), its concentration in the textile, the exposure routes and the frequency of 
use. The risk associated with anti-microbial textiles is usually evaluated via acute and chronic 
toxicity, skin sensitization and irritation, and the disturbance of skin ecology. For instance, 
silver may interact with so called ‘good’ bacteria such as skin flora to weaken the skin defense 
barrier,221, 222 and also lead to the deposition of Ag metal/Ag sulfide particles in skin, causing 
discoloration (argyria) or even ocular discoloration (argyrosis), which although not life 
threatening is cosmetically undesirable.221 
Future Directions and Conclusions  
Towards Smart and Sustainable Protective Clothing 
Smart wearable electronic textiles (e-textiles) are becoming increasingly popular due to their 
ability to make human life safer, healthier and more comfortable.97, 99 Such smart e-textiles 
could potentially interface with the human body, and continuously monitor, collect and 
communicate various physiological data and the vital signs of the wearer-including 
temperature, heart-rate and oxygen saturation level-and communicate these data wirelessly to 
a processing device. Such data relating to vital signs can alert health care professionals of any 
deterioration in a patient’s health at a very early stage and enable them to intervene more 
quickly. This could be considered to be particularly important in health care settings such as 
care homes where staffing shortages are a major issue. Smart textiles could also allow patients 
to monitor their health at home, thereby freeing up hospital beds. Self-monitoring of medical 
conditions with connected wearable devices could potentially reduce NHS costs by ~60%. In 
addition, the health and well-being of HCWs is immensely important in order to ensure that 
they are available to treat patients with infectious diseases, such as Covid-19. As such, e-
textiles could be a useful tool in monitoring the health of HCWs, who regularly experience 
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stress during long shifts or in operation theatres, and are exposed to several risks in their work 
environment. 
Smart wearable e-textiles technologies could be integrated with protective clothing to produce 
truly “Smart” wearable medical clothing, which can then continuously monitor the 
physiological conditions of both HCWs and patients, Figure 7a. Furthermore, recent studies 
have also shown promise in tracking Covid -19 symptoms continuously via wearable sensors, 
which could potentially monitor coughs, fever and respiratory activity. Researchers have 
developed such a wearable device, and are creating a set of data algorithms specifically tailored 
to detect early signs and symptoms associated with Covid-19, and to monitor patients as the 
illness progresses.223 Recently, we also reported washable, durable and flexible graphene-based 
wearable e-textiles, which are highly scalable, cost effective and potentially more 
environmentally friendly than existing metals -based technologies.98, 101-103 In addition, 
graphene and other 2D materials have drawn significant interest in flexible and wearable 
electronics applications, due to their outstanding electrical, mechanical, and other performance 
properties. Such properties could also be exploited in heterostructures,224 where different 2D 
materials are inkjet printed on top of each other via rapid, precise and reproducible deposition 
of controlled quantities of 2D materials in a non-impact, additive patterning and mask-less 
approach. Therefore, integrated graphene-based wearable e-textiles for protective clothing 
could potentiality address current challenges associated with the early detection of highly 
infectious diseases, ensuring good health and well-being of front-line workers. 
The outbreak of the Covid-19 pandemic has resulted in significant increases in the consumption 
of disposable face masks and gloves. Such plastic-based disposable items, used by the general 
public, are often not disposed of properly, thereby adding to the mass of plastic pollution which 
poses a significant threat to oceans and marine life.225 Recent news has highlighted concerns 
from conservationists about such “new” pollution, which is set to become ubiquitous after 
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millions of people around the world have turned to single-use plastic-based protective products 
(e.g. surgical mask made of polypropylene plastics) to help prevent the spread of Covid-19.226 
Such plastic-based products are not are biodegradable, and could stay in the environment for 
many years. In addition, used PPE is incinerated because it is classified as a bio-hazard. 
Increased volumes of PPE consumption as a result of the Covid-19 pandemic, and the 
subsequent incineration of these products will, in turn, contribute to increased carbon emissions 
which is also a problem. Therefore, the textile industry now has an opportunity to design new 
types of environmentally sustainable protective clothing that would be washable and reusable, 
which could potentially reduce the amount of medical waste contributing towards 
environmental pollution. In addition, new technologies that sterilize waste, and separate/reduce 
the mixing of infectious waste with general waste need to investigated urgently.227 
Furthermore, the use of biodegradable polymers (e.g. polylactic acid, PLA)228 and recycled 
polymers (e.g. rPET or rPP) for manufacturing protective clothing, and recycling of current 
disposable plastic-based protective clothing products would help to reduce the environmental 
impact, and support a shift towards more sustainable protective medical clothing and a circular 
economy. 
Towards Safe and Green Functional Materials and Techniques 
Although the benefits of anti-microbial textiles that protect the wearer from pathogens are 
evident, there are some concerns associated with the use of anti-microbial agents on textiles, 
including their potential to kill good flora bacteria from the skin, their toxic breakdown 
products and the consequent risks to human health and environment.50 It is important that the 
overall advantages and effectiveness of anti-microbial agents should outperform any the 
potential environmental concern and the cost of the product. Therefore, future anti-microbial 
agents should be highly effective at very low dosages while also being extremely durable to 
ensure the development of products with longer useful lives. Thus, in turn, will help to reduce 
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the quantities of textiles waste disposed of, and improve the overall carbon footprint associated 
with protective clothing. In addition, anti-microbial agents should not release unwanted toxic 
chemicals in aquatic environment, and should efficiently be removed via green and less energy 
intensive waste-water treatments. Furthermore, there must be efforts from researchers and 
manufacturers to develop safer and environment-friendly “green” agents, namely natural anti-
microbial agents, which may present an efficient anti-microbial effect, with safety, easy 
availability and nontoxicity to skin.229, 230 Natural biopolymers extracted from animals or 
plants-including chitosan, cyclodextrin, sericin and alginate-are renewable, and could be used 
as key resources for sustainable bioactive textiles, Figure 7c.231 Polyelemental nanoparticles 
(PE NPs) containing four or more elements in a single NP could also be explored to enable a 
multifunctional ant-microbial agent with a new physical and chemical phenomena.232
In addition to the growing interest in natural green anti-microbial agents, there has also been 
drive towards the introduction of green processing techniques in textile manufacturing due to 
rigorous ecological legislation and growing environmental concerns, Figure 7d. For example, 
a “solvent free” dry plasma treatment could be employed to apply anti-microbial finishes onto 
textiles. Unlike conventional treatments, the dry plasma treatment does not produce 
contaminated water or create mechanical hazards for treated fabrics.233 In addition, the uses of 
enzymes, UV radiation and ultrasound energy could be considered to be more environmentally 
friendly processes which promote the adhesion of natural dyes with anti-microbial 
properties.234, 235 Furthermore, a broader perspective and knowledge of anti-microbials, with 
considerations into risks and benefits of their use compared to alternative anti-microbial 
substances, is needed for the regulatory assessment of the single anti-microbial substance.66 
For example, it has been reported that the textile industry uses the highest amount of triclosan 
(~210 metric tonnes), which could be replaced by either <2 metric tonnes of silver 
nanoparticles or by ~180 metric tonnes of Si-QAC, achieving similar anti-microbial results but 
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with a lower environmental impacts.50 Microencapsulation of anti-microbial additives into 
textile polymer matrix could also be explored to avoid the human and environment safety level. 
New fibre or fabric manufacturing techniques such as electro-spinning and additive 
manufacturing could also be explored for making protective clothing with improved comfort 
and effective protections from pathogens.171, 236, 237
Towards Sustainable Supply Chain
The recent Covid-19 pandemic has resulted in unprecedented demand for PPE needed to 
protect the health of HCWs and prevent the spread of the disease. Hospitals around the world 
have experienced significant shortages in supplies of PPE, and the global supply chain was 
severely challenged216 due to rising demand, panic buying, hoarding and misuse. The shortage 
of safe and effective PPE has been one of the major causes for the deaths of frontline workers 
treating Covid-19 patients around the world. PPE prices have also increased significantly with 
long delay in supplies, widespread market manipulation, and stocks frequently sold to the 
highest bidder. As per WHO’s modelling, an estimated 89 million medical masks, 76 million 
gloves and 1.6 million googles are required for the Covid-19 response each month. The WHO 
has also recommended that the industry should increase the PPE production by ~40%.238 The 
WHO has additionally provided recommendations for the rational use of PPE in healthcare and 
community settings, and strategies to optimize the availability of PPE including minimizing 
the use of PPE, recommending the appropriate use of PPE and coordinating with the PPE 
supply chains.23 However, these are temporary measures to optimize the PPE supply chain in 
order to tackle  the current Covid-19 pandemic. Sustainable and commercial approaches are 
needed to avoid similar shortages into the future and could involve the followings. 
Firstly, the creation of government-backed local or regional (e.g. EU, America, South Asia, 
Middle East etc.) manufacturing, sourcing and distribution facilities for PPE, Figure 7e. 
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Secondly, the introduction of digital technologies in manufacturing and processing (e.g. water-
less colorations, inkjet printing, digital finishing techniques and 3D printing) of protective 
clothing. The traditional manufacturing and processing techniques of protective clothing may 
be challenging for some countries or regions such as the EU or US due to higher labor costs 
and the associated environmental legislation. Nevertheless, the introduction of new 
technologies including robotics, additive manufacturing and artificial intelligence (AI) in 
manufacturing facilities (Industry 4.0), would enable cost-effective manufacturing of such 
devices at scale, Figure 7f. Thirdly, governments should encourage and introduce legislations 
to increase the use of sustainable and reusable protective equipment to lessen any 
environmental impacts, Figure 7g. In addition, more effort and resources should be invested 
into the design and development of environmentally sustainable recycling processes for single-
use plastic-based PPE. Finally, governments should increase annual expenditure on research 
and development for developing innovative technologies to produce smart, highly effective 
and extremely durable PPE with longer useful life, as well monitoring the wearer’s 
physiological conditions, Figure 7h.      
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Vocabulary 
An anti-microbial is defined as any substance of natural, semi-synthetic or synthetic in origin 
that kills (biocidal) or inhibits (biostatic) the growth of pathogens but causes little or no damage 
to the host; Covid-19 is short form of coronavirus disease 2019 and it belongs to a large family of 
viruses called Coronaviruses (CoV);  virucidal agents attack and inactivate viruses outside of 
host cells by damaging their protein shell capsid, destroying the genetic materials such as RNA 
and DNA or damaging the virion structure;  Virustatic agents are used on surfaces to stop 
the growth of viruses; personal protective equipment (PPE) is equipment (such as gloves, 
eye protection, face masks etc.) to protect the user against health or safety risks at work;
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Figure 1 Structure of virus and mechanistic action. a) The structure of a corona virus; b) 
Relative size of various pathogens; c) Mechanism to invade a cell via a virus. d) Surface 
addition of viruses via electrostatic interaction.  
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Figure 2 History of viruses. a) The threat of viral diseases to humanity at various years with 
number of human deaths. b) Timeline of recent highly infectious viruses such as SARS, Swine 
Flu, MERS and Covid-19. 
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Figure 3 Personal protective equipment (PEE) for HCWs. a) A healthcare worker with safe 
PPEs such as gown, visor respirator, visor and gloves. Spunbond–meltblown–spunbond (SMS) 
laminate fabric used for the disposable medical gown. It provides protection from the liquid 
and blood at the same time maintaining comfort. b) Surgical mask with SMS structure which 
only provides protection against larger particles but not effective against airborne viruses. c) 
FFP2/N95 respirator which provide efficient protection against airborne viruses by stopping 
>95% of particles. d) Stages to put on PPEs for healthcare setting and e) steps to remove PPEs 
safely without any contamination. 
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Figure 4. Anti-microbial agents and their mechanism. a) Anti-microbial action via silver 
nanoparticle coated fabrics. b) Major pathways targeted by anti-microbial agents to inhibit or 
destroy pathogens. The chemical structure of some commonly used anti-microbial agents: c) 
Quaternary Ammonium Compounds (QAC), d) Triclosan, e) N-Halamines, f) Graphene Oxide, 
g) Silver Nanoparticles, h) Polypyrrole, i) Chitosan and j) Flavonoids.  
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Figure 5. Manufacturing processes for personal protective fabric. a) Weaving mechanism 
and woven fabric structure (inset), b) Knitting mechanism and knitted fabric structure (inset), 
c) Electrospinning process and resulting fabric with random orientation (inset), d) Spun-bond 
nonwoven fabric manufacturing technique, e) Melt-blown nonwoven fabric manufacturing 
technique. Application of anti-microbial finish into/on textiles: f) Hot melt extrusion process 
for melt-mixing anti-microbial additives to fibre polymers, g) Pad-dry-cure technique to apply 
anti-microbial finish on fabric and h) Exhaustion method to apply anti-microbial finish on 
fabric 
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Figure 6. Global personal protective equipment and clothing market and their 
environmental impacts. a) Value of the personal protective equipment market worldwide from 
2018 to 2025 in billion US dollars (Source: Statistica), b) Share of the leading exporters of 
personal protective products worldwide in 2019 (Source: Statistica), c) Protective Clothing 
Market in Healthcare/Medical Industry, By Region, 2019-2024 in USD Million (Source: 
Market and Market Research) d) PPE supply levels for doctors working in high risk areas in 
the UK during Covid-19 pandemic as of April 2020, e) Energy consumptions, water 
consumptions, greenhouse gas emission (GHG) and fibre production for polypropylene, 
polyester and cotton fibres, (f) Materials Sustainability Index (MSI) score for polypropylene, 
polyester and cotton fibres and g) Comparison of environmental impact of reusable (R) and 
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disposable (D) surgical gowns.152 NRE = natural resource energy, GWP = global warming 
potential.
Figure 7. Future research directions and recommendations. a) Smart wearable protective 
clothing that can monitor wearer physiological conditions such as temperature, heart rate and 
oxygen saturation level, b) Sustainable protective clothing which are reusable, washable and 
recyclable; c) The use of green, natural and novel materials for functional finishes on textiles, 
d) The use of digital technologies for processing protective clothing. e) Local manufacturing 
of personal protective clothing for healthcare applications, f) Industry 4.0 for manufacturing 
of protective clothing, g) Governments legislation for using sustainable PPE and h) Public and 
private funding in R&D to develop new and innovative technologies.    
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We review the current state-of-the-art in personal protective clothing used to protect the wearer 
from highly infectious diseases such as Covid-19. We provide an overview of protective 
medical fabric manufacturing techniques, their supply chains and environmental impacts with 
current single-used synthetic fibre-based protective clothing. Finally, we discuss future 
research directions, which include increasing efficiency, safety and availability of personal 
protective clothing worldwide without conferring environmental problems.   
Page 88 of 88
ACS Paragon Plus Environment
ACS Nano
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
